Search research articles
Contact Us
Filters
Showing results (211-220 of 217) with videos related to
Page
of 22
Sort By:
You have reached the last page of results.
This site can display upto 217 results.
Arthritis and Rheumatism
|
April 1, 1995
Cross-linked elastin and collagen degradation products in the urine of patients with scleroderma
P J Stone, J H Korn, H North, et al.
Annals of the New York Academy of Sciences
|
December 31, 1991
Validation of markers of lung destruction
B Burrows, D V Bates, M G Cosio, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 1, 1995
Elastin and collagen degradation products in urine of smokers with and without chronic obstructive pulmonary disease
P J Stone, D J Gottlieb, G T O'Connor, et al.
The American Review of Respiratory Disease
|
August 1, 1977
Attributes of the subspecialist in internal medicine and guidelines for training in pulmonary diseases
R D Miller, W H Anderson, J H Bates, et al.
Progress in Clinical and Biological Research
|
January 1, 1985
Biochemical properties and possible therapeutic role of the elastase inhibitor eglin C
H P Schnebli, U Seemüller, H Fritz, et al.
European Journal of Respiratory Diseases. Supplement
|
January 1, 1985
Eglin c, a pharmacologically active elastase inhibitor
H P Schnebli, U Seemüller, H Fritz, et al.
Pneumologie (Stuttgart, Germany)
|
February 3, 2005
[American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency]
J K Stoller, G L Snider, M L Brantly, et al.
Page
of 22
Search research articles
Search
Showing results (211-220 of 217) with videos related to
Sort By:
Page
of 22
You have reached the last page of results.
This site can display upto 217 results.
Arthritis and Rheumatism
|
April 1, 1995
Cross-linked elastin and collagen degradation products in the urine of patients with scleroderma
P J Stone, J H Korn, H North, et al.
Annals of the New York Academy of Sciences
|
December 31, 1991
Validation of markers of lung destruction
B Burrows, D V Bates, M G Cosio, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 1, 1995
Elastin and collagen degradation products in urine of smokers with and without chronic obstructive pulmonary disease
P J Stone, D J Gottlieb, G T O'Connor, et al.
The American Review of Respiratory Disease
|
August 1, 1977
Attributes of the subspecialist in internal medicine and guidelines for training in pulmonary diseases
R D Miller, W H Anderson, J H Bates, et al.
Progress in Clinical and Biological Research
|
January 1, 1985
Biochemical properties and possible therapeutic role of the elastase inhibitor eglin C
H P Schnebli, U Seemüller, H Fritz, et al.
European Journal of Respiratory Diseases. Supplement
|
January 1, 1985
Eglin c, a pharmacologically active elastase inhibitor
H P Schnebli, U Seemüller, H Fritz, et al.
Pneumologie (Stuttgart, Germany)
|
February 3, 2005
[American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency]
J K Stoller, G L Snider, M L Brantly, et al.
Page
of 22